Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17728023 | 0.92 | DGKA (0.52) | DGKAFAAHDNM1TSHRGMNN | |
| SCHEMBL11797938 | 0.89 | DGKA (0.44) | MGLLCNR2TRPV1DGKAFAAH | |
| SCHEMBL1681335 | 0.89 | DGKA (0.44) | MGLLCNR2TRPV1DGKAFAAH | |
| SCHEMBL4442294 | 0.89 | DGKA (0.44) | MGLLCNR2TRPV1DGKAFAAH | |
| SCHEMBL6114366 | 0.84 | TSHR (0.50) | DGKAFAAHTSHREPHX2GMNN | |
| SCHEMBL8858232 | 0.84 | TSHR (0.50) | DGKAFAAHTSHREPHX2LMNA | |
| SCHEMBL8858229 | 0.84 | TSHR (0.50) | DGKAFAAHTSHREPHX2LMNA | |
| SCHEMBL8468015 | 0.84 | TSHR (0.50) | DGKAFAAHTSHREPHX2GMNN | |
| SCHEMBL27884984 | 0.84 | TSHR (0.46) | DGKAFAAHDNM1TSHREPHX2 | |
| SCHEMBL22070461 | 0.82 | TSHR (0.47) | DGKAFAAHTSHREPHX2GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018029673-A1 | COMPOSITIONS COMPRISING DEAD SEA WATER AND POLYSACCHARIDES AND USES THEREOF AS SKIN PROTECTANTS | AHAVA - DEAD SEA LABORATORIES LTD. (IL) | 2018-02-15 | — | — | WO | disclosed |
| EP-2969960-A1 | PLANT-BASED COMPOSITIONS AND USES THEREOF | GreenStract, LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014145057-A1 | PLANT-BASED COMPOSITIONS AND USES THEREOF | GreenStract, LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-2579951-A2 | A HIGH HUMECTANT HIGH INTERNAL PHASE EMULSION | Unilever Plc (GB) | 2013-04-17 | — | — | EP | disclosed |
| EP-2557924-A1 | DERMAL PHARMACEUTICAL COMPOSITIONS OF 1-METHYL-2',6'-PIPECOLOXYLIDIDE AND METHOD OF USE | Relmada Therapeutics, Inc. (US) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011157640-A2 | A HIGH HUMECTANT HIGH INTERNAL PHASE EMULSION | UNILEVER PLC (GB) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011130455-A1 | DERMAL PHARMACEUTICAL COMPOSITIONS OF 1-METHYL-2',6'-PIPECOLOXYLIDIDE AND METHOD OF USE | BABUL NAJIB (US) | 2011-10-20 | — | — | WO | disclosed |
| EP-2349279-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF | The Board of Trustees of The Leland Stanford Junior University (US) | 2011-08-03 | — | — | EP | disclosed |
| EP-2265174-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND METHODS OF USE THEREOF | The Regents of the University of California (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2010102938-A1 | METHOD AND COMPOSITION FOR EVENLY APPLYING WATER SOLUBLE ACTIVES | UNILEVER PLC (GB) | 2010-09-16 | — | — | WO | disclosed |
| WO-2009123735-A1 | USE OF FUNCTIONALIZED MAGNETIC NANOPARTICLES IN CANCER DETECTION AND TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009123734-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-10-08 | — | — | WO | disclosed |
| WO-2008155228-A2 | STABLE HIGH INTERNAL PHASE EMULSIONS COMPOSITIONS THEREOF | UNILEVER PLC (GB) | 2008-12-24 | — | — | WO | disclosed |
| EP-2001458-A1 | USE OF VALPROIC ACID FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNE VULGARIS | TopoTarget Germany AG (DE) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007112832-A1 | USE OF VALPROIC ACID FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNE VULGARIS | TOPOTARGET GERMANY AG (DE) | 2007-10-11 | — | — | WO | disclosed |
| EP-1635808-A1 | TOPICAL USE OF VALPROIC ACID FOR THE PREVENTION OR TREATMENT OF SKIN DISORDERS | TopoTarget Germany AG (DE) | 2006-03-22 | — | — | EP | disclosed |
| WO-2005000289-A1 | TOPICAL USE OF VALPROIC ACID FOR THE PREVENTION OR TREATMENT OF SKIN DISORDERS | TOPOTARGET GERMANY AG (DE) | 2005-01-06 | — | — | WO | disclosed |
| EP-1438002-A1 | SILICONE ELASTOMER EMULSION COSMETIC COMPOSITION COMPRISING COLORANT INCLUSIVE INTERNAL PHASE | THE PROCTER & GAMBLE COMPANY (US) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035016-A1 | SILICONE ELASTOMER EMULSION COSMETIC COMPOSITION COMPRISING COLORANT INCLUSIVE INTERNAL PHASE | THE PROCTER & GAMBLE COMPANY (US) | 2003-05-01 | — | — | WO | disclosed |
| WO-1998048768-A9 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORP (US) | 1999-03-25 | — | — | WO | disclosed |